- Home
- ANEB vs FCAP Comparison
ANEB vs FCAP Comparison
Compare ANEB & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- FCAP
- Stock Information
- Founded
- ANEB 2020
- FCAP 1891
- Country
- ANEB United States
- FCAP United States
- Employees
- ANEB N/A
- FCAP N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- FCAP Savings Institutions
- Sector
- ANEB Health Care
- FCAP Finance
- Exchange
- ANEB Nasdaq
- FCAP Nasdaq
- Market Cap
- ANEB 111.8M
- FCAP 125.9M
- IPO Year
- ANEB 2021
- FCAP 1999
- Fundamental
- Price
- ANEB $2.76
- FCAP $42.79
- Analyst Decision
- ANEB Buy
- FCAP
- Analyst Count
- ANEB 2
- FCAP 0
- Target Price
- ANEB $8.00
- FCAP N/A
- AVG Volume (30 Days)
- ANEB 25.7K
- FCAP 3.9K
- Earning Date
- ANEB 11-12-2025
- FCAP 10-24-2025
- Dividend Yield
- ANEB N/A
- FCAP 2.89%
- EPS Growth
- ANEB N/A
- FCAP 25.19
- EPS
- ANEB N/A
- FCAP 4.41
- Revenue
- ANEB N/A
- FCAP $47,323,000.00
- Revenue This Year
- ANEB N/A
- FCAP N/A
- Revenue Next Year
- ANEB N/A
- FCAP N/A
- P/E Ratio
- ANEB N/A
- FCAP $9.74
- Revenue Growth
- ANEB N/A
- FCAP 15.22
- 52 Week Low
- ANEB $0.80
- FCAP $28.50
- 52 Week High
- ANEB $3.42
- FCAP $53.85
- Technical
- Relative Strength Index (RSI)
- ANEB 64.17
- FCAP 50.49
- Support Level
- ANEB $2.50
- FCAP $37.82
- Resistance Level
- ANEB $2.76
- FCAP $42.16
- Average True Range (ATR)
- ANEB 0.12
- FCAP 1.43
- MACD
- ANEB 0.03
- FCAP -0.37
- Stochastic Oscillator
- ANEB 85.00
- FCAP 48.54
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.